Mannkind Corp

NASDAQ: MNKD
$7.44
+$0.18 (+2.5%)
Closing Price on November 6, 2024

MNKD Articles

The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across these selected biotech stocks.
Short sellers made very few big moves between the July 29 and August 15 settlement dates, at least when it comes to the most shorted stocks traded on the Nasdaq.
The short interest data are out for the July 29 settlement date and short interest decreased across these selected biotech stocks.
Short sellers didn’t make any big moves between the July 15 and July 29 settlement dates, at least when it comes to the most shorted stocks traded on the Nasdaq.
The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected biotech stocks.
As the Brexit fears faded and the markets headed for new all-time highs, short sellers remained focused on their favorite stocks traded on the Nasdaq.
Among the most heavily shorted stocks traded on the Nasdaq, the moves between the June 15 and June settlement dates were mostly mixed and modest.
The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
These are the 10 NASDAQ stocks with the largest short positions base on share count for the period that ended June 15. Sirius XM Holdings Inc. (NASDAQ: SIRI) almost always tops the NASDAQ list, to...
The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. After all, a cure or...
The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Among the most heavily shorted stocks traded on the Nasdaq, the big mover between the May 13 and May 31 settlement dates was Apple.
Janus Capital has now launched the Obesity ETF, which has a strategy of investing in companies that provide treatment and care for obesity and obesity‐related disease.
The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
As the time of “sell in May and go away” arrived, it seems the short sellers were neither strongly for nor against the notion, as least as far as the most heavily shorted stocks traded on the...